company

RYFYLKE APOTEK AS

4150 RENNESØY

Return on Equity
25,75 %
Current Ratio
1,3
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue21 102 000
Net Income589 000
Total Assets9 463 000
Total Equity2 287 000
Income (NOK)2022
Revenue21 102 000
Expenditure20 514 000
Operating Profit588 000
Financial Income168 000
Financial Costs0
Financial Balance168 000
Earnings Before Tax755 000
Tax166 000
Net Income589 000
Balance (NOK)2022
Total Fixed Assets105 000
Total Current Assets9 358 000
Total Assets9 463 000
Total Retained Equity587 000
Total Equity2 287 000
Total Long-Term Debt0
Total Current Debt7 176 000
Total Equity and Debt9 463 000
Cash flow (NOK)2022
Sales Income21 030 000
Other Income72 000
Revenue21 102 000
Cost of Goods Sold15 759 000
Salary Costs3 733 000
Depreciation30 000
Impairment0
Expenditure20 514 000
Operating Profit588 000
Financial Income168 000
Financial Costs0
Financial Balance168 000
Dividends0
Net Income589 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets6 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures100 000
Total Tangible Assets100 000
Total Fiancial Fixed Assets0
Total Fixed Assets105 000
Stock1 170 000
Total Investments0
Cash, Bank276 000
Total Current Assets9 358 000
Total Assets9 463 000
Total Equity2 287 000
Short-Term Group Debt2 798 000
Total Long-Term Debt0
Creditors3 397 000
Unpaid Taxes503 000
Dividends0
Other Current Debt478 000
Total Current Debt7 176 000
Total Equity and Debt9 463 000
Financial indicators2022
Return on Equity25,75 %
Debt-to-Equity Ratio0
Operating Profit Margin2,79 %
Current Ratio1,3
Quick Ratio1,56
Equity Ratio0,24
Gross Profit Margin25,32 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English